Brief Description
CellASIC¨ ONIX Microfluidic Platform delivers precise control for live cell analysis experiments by facilitating long-term perfusion cell culture. Cutting-edge microfluidics technology provides an improved cell culture microenvironment, exceptional quality for high magnification microscopy, and superior media switching capabilities.
CallASIC Corp. was acquired by Merck and merged with EMD Millipore Corp. for € 21.7 million in cash in 2012.
Inventors
Ju Sung Hung, Luke Lee, Philip Lee